These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 21557456

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. What's up with down syndrome and leukemia-A lot!
    Taub JW, Ravindranath Y.
    Pediatr Blood Cancer; 2011 Jul 15; 57(1):1-3. PubMed ID: 21480471
    [No Abstract] [Full Text] [Related]

  • 3. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D, Tabuchi K, Kinoshita A, Hanada R, Kigasawa H, Tsukimoto I, Tsuchida M, Tokyo Children's Cancer Study Group.
    Pediatr Blood Cancer; 2007 Aug 15; 49(2):127-32. PubMed ID: 16807916
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Myelogenous leukemia in children. ANLL9205 study by Children's Cancer and Leukemia Study Group (CCLSG)].
    Mimaya J, Horikoshi Y, Shimizu H, Maeda H, Koizumi S, Kawakami K, Watanabe A, Utsumi J, Kikuta A, Oka T, Mugishima H, Kawamura N, Gushiken T, Ohta S, Yamamura Y, Ishida Y, Sekine I, Okada N, Fujimoto T.
    Rinsho Ketsueki; 1997 Feb 15; 38(2):100-7. PubMed ID: 9059063
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols.
    Khattab TM, Atra AA, Elimam NA, Kassar A, Zayed A, Baothman A.
    Saudi Med J; 2008 May 15; 29(5):776-7. PubMed ID: 18454233
    [No Abstract] [Full Text] [Related]

  • 18. Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia.
    Lee JH, Choi SJ, Lee JH, Lee YS, Seol M, Ryu SG, Jang S, Park CJ, Chi HS, Lee JS, Kim WK, Lee KH.
    Leuk Res; 2006 Feb 15; 30(2):204-10. PubMed ID: 16055185
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G, Leverger G, Leblanc T, Nelken B, Baruchel A, Landman-Parker J, Thuret I, Bergeron C, Bordigoni P, Esperou-Bourdeau H, Perel Y, Vannier JP, Schaison G.
    Bone Marrow Transplant; 1996 Feb 15; 17(2):191-6. PubMed ID: 8640165
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.